Incidence and Risk Factors for Cognitive Dysfunction in Patients with Severe Systemic Disease

Author： Radtke FM Franck M Herbig TS Papkalla N Kleinwaechter R Kork F Brockhaus WR Wernecke K-D Spies CD

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.40, Iss.2, 2012-03, pp. : 612-620

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cognitive enhancers provide some benefits in patients with moderate to severe Alzheimer's disease

Drugs & Therapy Perspectives, Vol. 27, Iss. 4, 2011-04 ,pp. : 9-15

Adis International

Access to resources Recommend Favorite

Incidence and risk factors of pleural effusions in patients with POEMS syndrome

Hematological Oncology (Electronic), Vol. 33, Iss. 2, 2015-06 ,pp. : 80-84

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence and Risk of Severe Neutropenia in Advanced Cancer Patients Treated with Cetuximab: A Meta-Analysis

By Wang Long

Drugs in R&D, Vol. 11, Iss. 4, 2011-12 ,pp. : 317-326

Adis International

Access to resources Recommend Favorite

Rituximab: Severe disease exacerbation in patients with systemic lupus erythematosus and anti-phospholipid syndrome: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1238, 2009-01 ,pp. : 30-30

Adis International

Access to resources Recommend Favorite

Epratuzumab decreases disease activity and steroid use in patients with moderate and severe flaring systemic lupus erythematosis

Inpharma, Vol. 1, Iss. 1645, 2008-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite